A Thyroid Antibody Primer in Graves' Disease | oneGRAVESvoice

Trusted Resources: Evidence & Education

Scientific literature and patient education texts

Back to Evidence & Education / Reference Materials

A Thyroid Antibody Primer in Graves’ Disease

key information

source: Medscape

year: 2021

authors: Karen Tsai, Trevor E. Angell, Melissa G. Lechner

summary/abstract:

A healthy 52-year-old woman has had persistent palpitations recently. Serum TSH is < 0.02 mIU/mL (reference, 0.3-4.7 mIU/mL), free T4 is 5.70 ng/dL (reference, 0.8-1.7 ng/dL), and free triiodothyronine (T3) is 1920 pg/dL (reference, 222-383 pg/nL). She has fine bilateral hand tremors and sinus tachycardia. How do we work up this new diagnosis of thyrotoxicosis?

This is one of the most common consults we receive. Thyroid antibodies may be helpful in teasing apart the differential diagnosis of thyrotoxicosis.

TSH receptor antibodies (TRAb) target the TSH receptor and may have an inhibitory, neutral, or stimulating effect. The thyrotropin binding inhibitory immunoglobulin (TBII) test measures antibodies that inhibit TSH binding to its receptor. Stimulating TRAbs, known as thyroid-stimulating immunoglobulins (TSIs), are associated with Graves’ disease; they stimulate the TSH receptor, leading to increased production and release of thyroid hormone. Though the names may vary in commercial labs, positive TBII, TRAb, or TSI titers can all be used to diagnose Graves’ disease.

 

read more

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close